Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Exchange Rate Effect (2023 - 2025)

Tonix Pharmaceuticals Holding has reported Exchange Rate Effect over the past 3 years, most recently at -$14000.0 for Q4 2025.

  • Quarterly results put Exchange Rate Effect at -$14000.0 for Q4 2025, down 158.33% from a year ago — trailing twelve months through Dec 2025 was -$31000.0 (down 875.0% YoY), and the annual figure for FY2025 was -$31000.0, down 875.0%.
  • Exchange Rate Effect for Q4 2025 was -$14000.0 at Tonix Pharmaceuticals Holding, down from -$4000.0 in the prior quarter.
  • Over the last five years, Exchange Rate Effect for TNXP hit a ceiling of $24000.0 in Q4 2024 and a floor of -$43000.0 in Q1 2023.
  • Median Exchange Rate Effect over the past 3 years was -$9000.0 (2025), compared with a mean of -$8363.6.
  • Biggest five-year swings in Exchange Rate Effect: skyrocketed 340.0% in 2024 and later crashed 500.0% in 2025.
  • Tonix Pharmaceuticals Holding's Exchange Rate Effect stood at -$10000.0 in 2023, then surged by 340.0% to $24000.0 in 2024, then tumbled by 158.33% to -$14000.0 in 2025.
  • The last three reported values for Exchange Rate Effect were -$14000.0 (Q4 2025), -$4000.0 (Q3 2025), and -$4000.0 (Q2 2025) per Business Quant data.